SureTrader SureTrader
Home > Boards > US OTC > Medical - Equipment >

Pressure BioSciences, Inc. (PBIO)

PBIO RSS Feed
Add PBIO Price Alert      Hide Sticky   Hide Intro
Moderator: ProfitScout
Search This Board:
Last Post: 12/9/2016 12:56:48 PM - Followers: 37 - Board type: Free - Posts Today: 1

       
       
             

 

(PBIO)  Pressure BioSciences Inc.   

Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications.

                                                                               http://www.pressurebiosciences.com 

IDecember 2, 2016 - Pressure Biosciences featured on Barron's Financial Site: http://www.barrons.com/articles/PR-CO-20161202-907681
 

                                                     


 

             COMPANY NEWS
 


Pressure BioSciences, Inc. Reports Third Quarter 2016 Financial Results and Provides Business Update (Nov 21, 2016)

Pressure BioSciences (PBIO) Achieves Record Revenue on Road to Profitability -- SECFilings.com
 (Nov 16, 2016)

Pressure BioSciences, Inc. Reports Third Quarter 2016 Financial Results and Provides Business Update (Nov 21, 2016)

Pressure BioSciences Announces Initial Close of $610,000 in $2.5 Million Private Placement 
(Nov 14, 2016)
Pressure BioSciences (PBIO) Secures Funding Allowing for Accelerated Corporate Development -- SECFilings.com
 (Nov 04, 2016)
Pressure BioSciences, Inc. Closes $2,000,000 Line-of-Credit
 (Nov 03, 2016)
Pressure BioSciences' PCT Platform Featured at Official Launch of Major Cancer Research Center Recently Chosen as a Collaborator in the US "Cancer Moonshot" Initiative
October 26, 2016

Pressure BioSciences, Inc. to Present at the Fall SeeThruEquity Microcap Investment Conference in New York City
Oct. 17, 2016
SeeThruEquity Issues Update on Pressure BioSciences (OTCQB: PBIO)

October 14, 2016 
Cancer Moonshot Should Benefit Pharma Companies, Investors
Sept, 6, 2016
Pressure BioSciences, Inc. Reports Second Quarter 2016 Financial Results and Provides Business Update

Aug. 16, 2016
StockWatchIndex Research Report
July 21, 2016
Pressure BioSciences Unveils Barocycler 2320EXT at Major Scientific Meeting; Next Generation PCT-based Instrument Expected to be Centerpiece of the Recently Announced Co-Marketing Agreement with Global Life Sciences Analytical Technologies Leader SCIEX

July 13, 2016

 
Videos   
   
 

CEO Interview: Richard Schumacher of (OTCQB: PBIO) w/ TheStreet.com Analyst John Persinos
Aug 25, 2016


Pressure BioSciences: Game-Changing Tech for $6B Life Sciences Sample Prep Market
Aug 3, 2016



 


Jane King Interviews the CEO of Pressure Biosciences, Inc. (OTCQB: PBIO) 
July 21, 2016


Pressure BioSciences (OTC:QB PBIO) CEO (Richard Schumacher - First Look EquitiesInvestor Summit. 
June 5, 2016



 



SNNLive Newscast with Pressure BioSciences, Inc. (OTCQB: PBIO)
June 2, 2016


Pressure BioSciences, Inc. (PBIO) CEO Richard Schumacher at the US HPO Conference on iTownHall
March 15, 2016
 


 
         

DISCLAIMER

Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have positions in the stocks or financial relationships with the company or companies discussed and may trade in the stocks mentioned. Readers are advised to conduct their owndue diligence prior to considering buying or selling any stock. All information should be considered for information purposes only. No stock exchange has approved or disapproved of the information here.

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PBIO
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PBIO News: PBIO Targets Multi-Billion Dollar Opportunity 12/08/2016 08:00:00 AM
PBIO News: Quarterly Report (10-q) 11/15/2016 03:29:41 PM
PBIO News: Notification That Quarterly Report Will Be Submitted Late (nt 10-q) 11/15/2016 03:17:11 PM
PBIO News: Current Report Filing (8-k) 11/03/2016 05:31:12 PM
PBIO News: Pressure BioSciences, Inc. Closes $2,000,000 Line-of-Credit Access to Capital 11/03/2016 01:26:23 PM
PostSubject
#608  Sticky Note Excellent investor conference call today given by PBIO's ProfitScout 11/16/16 06:13:07 PM
#630   Hasnt PBIO learned yet that these PAID FOR namtae 12/09/16 12:56:48 PM
#629   PBIO Targets Multi-Billion Dollar Opportunity ProfitScout 12/08/16 09:20:42 AM
#628   * * $PBIO Video Chart 12-07-16 * * ClayTrader 12/07/16 04:36:00 PM
#627   Pressure Biosciences CEO On Its Beaten Down Stock: ProfitScout 12/06/16 02:29:42 PM
#626   Watching the Numbers for Pressure BioSciences, Inc. ProfitScout 12/06/16 11:09:22 AM
#624   PBIO has articles and video interviews and equity namtae 12/05/16 10:48:30 AM
#623   Mass Spectrometry Adopted by Clinical Laboratories Around the World ProfitScout 12/02/16 10:53:25 AM
#621   Again, you sold. So what is your lars1551 11/30/16 12:46:52 PM
#620   Miracles? namtae 11/30/16 08:47:26 AM
#619   I have owned this stock for years. lars1551 11/30/16 08:12:22 AM
#618   I couldnt agree more!! namtae 11/29/16 02:38:03 PM
#617   I'm sure you know far more than the lars1551 11/29/16 01:56:22 PM
#616   Who in their right mind is purchasing restricted namtae 11/28/16 11:12:01 AM
#615   PBIO: Update on Third Quarter Financials ProfitScout 11/22/16 10:33:04 AM
#614   Pressure BioSciences (PBIO) Achieves Record Revenue on Road ProfitScout 11/21/16 12:20:01 PM
#613   The call must have been great! Look at namtae 11/18/16 02:26:16 PM
#612   Everyone who has questions on PBIO should absolutely ProfitScout 11/17/16 03:56:02 PM
#610   Whatever was said on the CC is no namtae 11/17/16 09:03:16 AM
#609   Agree lars1551 11/17/16 07:39:22 AM
#608   Excellent investor conference call today given by PBIO's ProfitScout 11/16/16 06:13:07 PM
#607   Pressure BioSciences, Inc. Reports Third Quarter 2016 Financial ProfitScout 11/16/16 12:40:11 PM
#606   Today we will have a live investor teleconference ProfitScout 11/16/16 09:23:47 AM
#605   Sorrowful 10Q namtae 11/16/16 08:48:45 AM
#604   Pressure BioSciences Announces Initial Close of $610,000 in ProfitScout 11/14/16 09:58:09 AM
#603   Pressure BioSciences, Inc. to Discuss Third Quarter 2016 ProfitScout 11/11/16 12:43:07 PM
#602   WOW, this ceo is some kind of spin doctor!! namtae 11/06/16 09:38:57 AM
#601   Pressure BioSciences (PBIO) Secures Funding Allowing for Accelerated ProfitScout 11/04/16 09:33:23 AM
#600   Pressure BioSciences, Inc. Closes $2,000,000 Line-of-Credit ProfitScout 11/04/16 09:07:54 AM
#599   Today's news from PBIO is especially encouraging. Significant ProfitScout 11/03/16 01:16:01 PM
#597   Pressure BioSciences (PBIO) Uses Pressure to Aid Cancer Research ProfitScout 11/03/16 09:01:08 AM
#596   Doesnt make my point any less true about PBIO namtae 11/02/16 02:12:23 PM
#595   Pretty sure you sold, not sure why you care. lars1551 11/02/16 01:09:47 PM
#594   Yes, PBIO is building on all the company's ProfitScout 11/02/16 01:03:02 PM
#593   Please explain how a reverse split dilutes shareholders. namtae 11/02/16 12:58:25 PM
#592   They will need it for an up list though. IPO$ 11/02/16 12:46:33 PM
#591   The 14a does not announce a reverse split lars1551 11/02/16 12:20:33 PM
#590   Take the time to watch this interview video ProfitScout 11/02/16 10:57:17 AM
#589   Agree IPO$ 11/02/16 10:45:22 AM
#588   The CEO of Pressure BioSciences has done several ProfitScout 11/02/16 10:01:11 AM
#587   Is an uplist to a senior exchange coming? IPO$ 11/02/16 09:50:35 AM
#586   Pressure BioScience (PBIO) could be an Important Company ProfitScout 11/02/16 08:54:49 AM
#585   Most of this latest interview with CEO Richard ProfitScout 11/01/16 12:39:06 PM
#584   This latest interview with Richard Schumacher, CEO of ProfitScout 11/01/16 11:02:34 AM
#583   IN-DEPTH INTERVIEW WITH CEO OF GROUND BREAKING LIFE ProfitScout 11/01/16 10:55:58 AM
#582   Very interesting stuff thats not helping share price namtae 10/28/16 11:42:51 AM
#581   Pressure BioSciences' PCT Platform Featured at Official Launch ProfitScout 10/27/16 03:48:40 PM
#577   Eight questions namtae 10/23/16 07:00:13 PM
#576   Pressure BioSciences CEO Richard Schumacher is very good ProfitScout 10/23/16 03:50:15 PM
#575   Red Chip Research feature on Pressure BioSciences (PBIO) ProfitScout 10/23/16 03:25:28 PM
#573   Sure glad I dumped my remaining position of namtae 09/23/16 03:04:34 PM
PostSubject